Ultragenyx Pharmaceutical (RARE) Q3 2026 Earnings

30JulConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-1.84
-1.59
-1.34
-1.09

Details

Expected EPS
-1.218974
Actual EPS
N/A
Surprise EPS
1.22
Surprise Percent
+100%

Description

Ultragenyx Pharmaceutical (RARE) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts